ISSUE #64 – With his app tailored to the Singapore market, UEX CEO, Grégoire Rastoul looks to enable a more holistic approach to health insurance. How was the idea for
ISSUE #64 – Acute and chronic wounds affect an increasing fraction of the world population. In this interview, Paul Basson, Regional Director Asia, URGO, shares with us about the
ISSUE #64 – In late 2016, Singapore approved a dengue vaccine developed by Sanofi, Cyril Grandchamp-Desraux, Singapore Country Chair and Asia Head, General Medicines & Emerging Markets, tells us
ISSUE #64 – Singapore has positioned itself well as a leading medtech and biotech hub. In this interview, Emmanuel Montet, General Manager Singapore and ASEAN Director, Ipsen Specialty Care, shares
ISSUE #64 – Alexandre Civière, Project Manager at CellProthera, talks about research and breakthroughs in the regeneration of heart muscle after a severe heart attack and the prevention
ISSUE #64 – An ageing population presents both challenges and opportunities. Fabien Clavier, Lead Project Manager and Angela Saenz, Project Manager, IPAL CNRS (Singapore) tell us more about IPAL
ISSUE #64 – Rocio Martin, R&D Director at Danone Nutricia Research Singapore, talks allergy biomarkers detection early in life, enhanced microbial start for c-section babies and future endeavours
ISSUE #64 – Medical advice is now within reach for populations that were once overlooked. Emmanuel Prado, CEO of Health2i, tells us about the mobile app that is making
ISSUE #64 – In vitro diagnostics play a pivotal role: between 60% and 70% of healthcare decisions are based on diagnostic test results. Florent Mulatero, General Manager, bioMérieux ASEAN,
ISSUE #64 – Innovation beyond the product or the pill is more important than ever to address Singapore’s emerging health needs. Carole Real, Business Development Manager, and Yann Ferrisse,
